Publicaciones en las que colabora con Mario Fernández Fraga (11)

2009

  1. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 51, pp. 21830-21835

  2. The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA

    Nucleic Acids Research, Vol. 37, Núm. 8, pp. 2658-2671

2008

  1. Cancer genes hypermethylated in human embryonic stem cells

    PLoS ONE, Vol. 3, Núm. 9

  2. Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas

    Oncogene, Vol. 27, Núm. 36, pp. 4969-4972

  3. Promoter DNA hypermethylation and gene repression in undifferentiated arabidopsis cells

    PLoS ONE, Vol. 3, Núm. 10

  4. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins

    Oncogene, Vol. 27, Núm. 25, pp. 3556-3566

2007

  1. Combinatorial effects of splice variants modulate function of Aiolos

    Journal of Cell Science, Vol. 120, Núm. 15, pp. 2619-2630

2006

  1. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer

    Cancer Research, Vol. 66, Núm. 17, pp. 8342-8346

  2. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

    Nature Genetics, Vol. 38, Núm. 5, pp. 566-569

2005

  1. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma

    Cancer Research, Vol. 65, Núm. 7, pp. 2565-2571

  2. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients

    Human Genetics, Vol. 116, Núm. 1-2, pp. 91-104